Barclays logo
Barclays

May 26, 2026

Americas Small Cap Research Summary

Market ReportEquitiesFinancialsHealth Care

This Barclays research summary provides updates on Americas small-cap stocks including Cushman & Wakefield, Arvinas, Braze, and Tenable Holdings, following recent investor events and trial results.

Key Takeaways

  • 1.Tenable Holdings expects to reach the 'Rule of Forty' financial performance metric by the end of FY29.
  • 2.The failure of the LUMA trial (BIIB122) for Parkinson's disease is considered to have a limited impact on the core investment thesis for Arvinas (ARVN).
  • 3.Braze Inc. is positioned for a favorable 1Q27 setup driven by strong enterprise bookings momentum and an easier year-over-year comparison.

Table of Contents

  • Summary of Changes
  • Publications Summary
  • Financial Services
  • Healthcare
  • Technology
  • Analyst(s) Certification(s)
  • Important Disclosures
  • Availability of Disclosures
  • Risk Disclosure(s)
  • Guide to the Barclays Fundamental Equity Research Rating System
  • Stock Rating
  • Industry View
  • Distribution of Ratings
  • Guide to the Barclays Research Price Target
  • Types of investment recommendations produced by Barclays Equity Research
  • Disclosure of other investment recommendations produced by Barclays Equity Research
  • Legal entities involved in producing Barclays Research
  • Disclaimer

Document Preview

Page 1 of 5
Page 1 of Americas Small Cap Research Summary
Subscribe for full access

Access the Full Report

Get unlimited access to institutional research reports with a 14-day free trial.

Authors

Brendan LynchEtzer DaroutRaimo LenschowSaket Kalia

Securities

TENBARVNBRZECWKBIIB

Themes

Rule of FortyClinical Trial Read-throughsEnterprise Software Bookings Momentum

Regions

North AmericaUnited StatesCanada